By Kate Knibbs, Emily MullinOct 23, 2024, 10:27 am217 ptsTrending
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical companies and compounders.
Wired
